Home Cart Sign in  
Chemical Structure| 1446711-81-4 Chemical Structure| 1446711-81-4
Chemical Structure| 1446711-81-4

Acoramidis

CAS No.: 1446711-81-4

Acoramidis inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin.

Synonyms: AG10

4.5 *For Research Use Only !

Cat. No.: A1495434 Purity: 99%

Change View

Size Price

US Stock

Global Stock

In Stock
5mg łÇÊò¶ÊÊ Inquiry Inquiry
10mg łÇÿó¶ÊÊ Inquiry Inquiry
25mg ł§ÊǶÊÊ Inquiry Inquiry
50mg łÿÇǶÊÊ Inquiry Inquiry
100mg łóòî¶ÊÊ Inquiry Inquiry

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 5mg

    łÇÊò¶ÊÊ

  • 10mg

    łÇÿó¶ÊÊ

  • 25mg

    ł§ÊǶÊÊ

  • 50mg

    łÿÇǶÊÊ

  • 100mg

    łóòî¶ÊÊ

In Stock

- +

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of Acoramidis

CAS No. :1446711-81-4
Formula : C15H17FN2O3
M.W : 292.30
SMILES Code : O=C(O)C1=CC=C(F)C(OCCCC2=C(C)NN=C2C)=C1
Synonyms :
AG10

Safety of Acoramidis

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03536767 Amyloid Cardiomyopathy PHASE2 ACTIVE_NOT_RECRUITING 2025-07-27 Stanford University, Palo Alto... More >>, California, 94304, United States|University of California San Francisco, San Francisco, California, 94143, United States|Yale University, New Haven, Connecticut, 06520, United States|Northwestern University, Chicago, Illinois, 60611, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Columbia University, New York, New York, 10032, United States|Oregon Health & Science University, Portland, Oregon, 97239, United States|Medical University of South Carolina, Charleston, South Carolina, 29424, United States Less <<
NCT04882735 Transthyretin-Related (ATTR) F... More >>amilial Amyloid Polyneuropathy Less << PHASE3 WITHDRAWN 2025-10-26 -
NCT04958135 Healthy PHASE1 COMPLETED 2021-08-17 Celerion, Lincoln, Nebraska, 6... More >>8502, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.42mL

0.68mL

0.34mL

17.11mL

3.42mL

1.71mL

34.21mL

6.84mL

3.42mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories